A new trading day began on Tuesday, with Jaguar Health Inc (NASDAQ: JAGX) stock price down -4.42% from the previous day of trading, before settling in for the closing price of $1.13. JAGX’s price has ranged from $0.95 to $30.86 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 39.38%. Meanwhile, its annual earnings per share averaged 99.27%. With a float of $7.71 million, this company’s outstanding shares have now reached $9.24 million.
Let’s determine the extent of company efficiency that accounts for 49 employees. In terms of profitability, gross margin is 62.51%, operating margin of -308.15%, and the pretax margin is -355.51%.
Jaguar Health Inc (JAGX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Jaguar Health Inc is 16.61%, while institutional ownership is 1.11%.
Jaguar Health Inc (JAGX) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -41.4 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 99.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to 86.10% growth over the previous five years of trading.
Jaguar Health Inc (NASDAQ: JAGX) Trading Performance Indicators
Here are Jaguar Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -37.55, a number that is poised to hit -2.37 in the next quarter and is forecasted to reach -2.61 in one year’s time.
Technical Analysis of Jaguar Health Inc (JAGX)
Looking closely at Jaguar Health Inc (NASDAQ: JAGX), its last 5-days average volume was 0.29 million, which is a drop from its year-to-date volume of 0.77 million. As of the previous 9 days, the stock’s Stochastic %D was 9.76%. Additionally, its Average True Range was 0.08.
During the past 100 days, Jaguar Health Inc’s (JAGX) raw stochastic average was set at 3.73%, which indicates a significant decrease from 4.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.42% in the past 14 days, which was lower than the 160.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1733, while its 200-day Moving Average is $4.6638. However, in the short run, Jaguar Health Inc’s stock first resistance to watch stands at $1.1633. Second resistance stands at $1.2467. The third major resistance level sits at $1.2933. If the price goes on to break the first support level at $1.0333, it is likely to go to the next support level at $0.9867. Now, if the price goes above the second support level, the third support stands at $0.9033.
Jaguar Health Inc (NASDAQ: JAGX) Key Stats
With a market capitalization of 9.98 million, the company has a total of 9,241K Shares Outstanding. Currently, annual sales are 9,760 K while annual income is -41,300 K. The company’s previous quarter sales were 2,720 K while its latest quarter income was -9,490 K.
